- Fund Type: ETF
- Objective: Global Debt
- Asset Class: Debt
- Geographic Focus: Global
db x-trackers II iBoxx EUR Liquid Covered UCITS ETF
+ Add to WatchlistXLIQ:GR
138.6000 EUR 0.0100 0.01%As of 02:15:28 ET on 05/24/2013.
Snapshot for db x-trackers II iBoxx EUR Liquid Covered UCITS ETF (XLIQ)
| Open: | 138.6000 | High - Low: | 138.6000 - 138.6000 | Primary Exchange: | Xetra ETF |
|---|---|---|---|---|---|
| Volume: | 0 | 52-Week Range: | 131.9500 - 139.6900 | Beta vs IBXXECVT: | - |
Fund Profile & Information for XLIQ
db x-trackers II IBOXX EUR Liquid Covered UCITS ETF is a UCITS IV compliant exchange traded investment fund registered in Luxembourg. The investment objective of the ETF is to track the performance before fees and expenses of the IBOXX EUR LIQUID COVERED INDEX® Index by investing in transferable securities and using index swap agreements.
| Inception Date: | 2012-11-27 | Telephone: | 49-69-910-30549 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.dbxtrackers.de | ||
Fundamentals for XLIQ
| NAV | (on 2013-05-21) 138.9620 |
|---|---|
| Assets (M) | (on 2013-05-22) 6.9584 |
| Shares out (M) | 0.05 |
| Market Cap (M) | 6.93 |
| % Premium | -0.20 |
| Average 52-Week % Premium | -0.3364 |
| Fund Leveraged | N |
Dividends for XLIQ
No dividends reported
Performance for XLIQ
| 1-Month | +0.01% | 1-Year | - |
|---|---|---|---|
| 3-Month | +2.23% | 3-Year | - |
| Year To Date | +1.92% | 5-Year | - |
| Expense Ratio | 0.20 |
Top Fund Holdings for XLIQ
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| DBR 6 ½ 07/04/27 | 1,500 | 2,419,541 | 34.689% |
| CFF 3 ¾ 01/24/17 | 1,250 | 1,389,683 | 19.924% |
| ABBEY 3 ⅜ 06/08/15 | 1,250 | 1,325,825 | 19.008% |
| DBR 3 ¾ 01/04/17 | 1,000 | 1,132,374 | 16.235% |
| DBR 3 ¾ 01/04/19 | 550 | 652,167 | 9.350% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page